These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39127177)

  • 1. Are the new 2023 ACR/EULAR classification criteria suitable for advancing the knowledge of obstetric antiphospholipid syndrome?
    Martínez-Taboada VM; Gómez AM; Merino A; López-Hoyos M; Del Barrio-Longarela S; Comins-Boo A; Galvez R; Hernández JL
    Autoimmun Rev; 2024; 23(7-8):103592. PubMed ID: 39127177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
    Gao R; Qin L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):513-520. PubMed ID: 38948301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Antiphospholipid antibody solid phase-based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome": reply.
    Huisman A; Urbanus RT; Meijer P
    J Thromb Haemost; 2024 Aug; 22(8):2373-2374. PubMed ID: 39048272
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical relevance of the recent update of the classification criteria for definite antiphospholipid syndrome: an obstetric medicine clinic series of 107 patients.
    Pourrat O; Jollit C; Gombert JM; Boinot C; Pierre F
    J Thromb Haemost; 2006 Oct; 4(10):2276-7. PubMed ID: 16869832
    [No Abstract]   [Full Text] [Related]  

  • 5. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
    Miyakis S; Lockshin MD; Atsumi T; Branch DW; Brey RL; Cervera R; Derksen RH; DE Groot PG; Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani A; Vlachoyiannopoulos PG; Krilis SA
    J Thromb Haemost; 2006 Feb; 4(2):295-306. PubMed ID: 16420554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does seronegative obstetric APS exist? "pro" and "cons".
    Conti F; Andreoli L; Crisafulli F; Mancuso S; Truglia S; Tektonidou MG
    Autoimmun Rev; 2019 Dec; 18(12):102407. PubMed ID: 31639518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification criteria for the antiphospholipid syndrome--the next modification].
    Zimmermann-Górska I
    Pol Arch Med Wewn; 2006 May; 115(5):396-400. PubMed ID: 17195350
    [No Abstract]   [Full Text] [Related]  

  • 8. Limited evidence for diagnosing and treating "non-criteria obstetric antiphospholipid syndrome".
    Ramires de Jesús G; Levy RA; Porter TF; Branch DW
    Thromb Haemost; 2015 Aug; 114(3):651-2. PubMed ID: 25947158
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiphospholipid syndrome in pregnancy--contemporary opinions concerning pathogenesis and diagnostic criteria].
    Matusiak-Kita M; Murawski M; Gryboś M
    Wiad Lek; 2009; 62(1):21-5. PubMed ID: 19817253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASSESSING THE PATIENT WITH ANTIPHOSPHOLIPID SYNDROME IN LIGHT OF THE NEW 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CLASSIFICATION CRITERIA - CASE REPORT.
    Archaia N; Chumburidze V; Kakauridze N
    Georgian Med News; 2024 Apr; (349):36-40. PubMed ID: 38963198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications.
    Geis W; Branch DW
    Clin Obstet Gynecol; 2001 Mar; 44(1):2-10. PubMed ID: 11219242
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria.
    Vasi İ; Kardaş RC; Ekici M; Yıldırım D; Kaya B; Duran R; Karadeniz H; Güler AA; Küçük H; Göker B; Bilgen ŞA; Tufan A; Öztürk MA; Erden A
    Int J Rheum Dis; 2024 May; 27(5):e15175. PubMed ID: 38720575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical consequences of antiphospholipid antibodies.
    Derksen RH; de Groot PG
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2023 ACR/EULAR classification criteria in existing research cohorts: an international study.
    Foddai SG; Radin M; Cecchi I; Rubini E; Barinotti A; Alba P; Gimen Alonso C; Rossi D; Roccatello D; Sciascia S
    Rheumatology (Oxford); 2024 Oct; 63(10):2770-2775. PubMed ID: 38290789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of antiphospholipid antibodies in obstetrics.
    Matraszek VV; Heřman H; Hromadníková I
    Ceska Gynekol; 2024; 89(3):237-244. PubMed ID: 38969520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent miscarriages in women not fulfilling classification criteria for antiphospholipid antibody syndrome.
    Proietta M; Ferrero S; Ferri L; Cifani N; Bruno G; Del Porto F
    Int J Immunopathol Pharmacol; 2014; 27(3):429-32. PubMed ID: 25280034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
    Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
    Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
    Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
    Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiphosphatidylethanolamine antibody as a marker of antiphospholipid syndrome?].
    Yelnik CM; Dubucquoi S; Houfflin-Debarge V; Lambert M
    Presse Med; 2015 Mar; 44(3):284-91. PubMed ID: 25542711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective.
    Spinillo A; Bellingeri C; De Maggio I; Riceputi G; Pandolfi MP; Spada C; Alpini C; Montecucco C; Beneventi F
    J Reprod Immunol; 2021 Jun; 145():103304. PubMed ID: 33677238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.